HSBC Holdings
STRO icon

HSBC Holdings’s Sutro Biopharma STRO Stock Holding History

HSBC Holdings’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,474
Closed -$18.1K – 3112
2025
Q2 		$18.1K Sell
2,474
-3,572
-59% -$29.2K ﹤0.01% 2982
2025
Q1 		$40.3K Sell
6,046
-309
-5% -$4.87K ﹤0.01% 2928
2024
Q4 		$116K Sell
6,355
-1,812
-22% -$55.3K ﹤0.01% 2863
2024
Q3 		$285K Buy
8,167
+2,081
+34% +$81.6K ﹤0.01% 2383
2024
Q2 		$173K Buy
6,086
+541
+10% +$21.4K ﹤0.01% 2607
2024
Q1 		$313K Buy
5,545
+305
+6% +$13.5K ﹤0.01% 2422
2023
Q4 		$223K Buy
5,240
+2,463
+89% +$78.2K ﹤0.01% 2418
2023
Q3 		$97.6K Buy
+2,777
New +$121K ﹤0.01% 2555
2023
Q2 		– Sell
-1,941
Closed -$87.5K – 2741
2023
Q1 		$87.5K Buy
1,941
+145
+8% +$9.2K ﹤0.01% 2521
2022
Q4 		$139K Buy
1,796
+383
+27% +$26.6K ﹤0.01% 2852
2022
Q3 		$79K Buy
1,413
+157
+13% +$9.29K ﹤0.01% 2774
2022
Q2 		$66K Buy
+1,256
New +$70.2K ﹤0.01% 3105
2020
Q4 		– Sell
-1,614
Closed -$165K – 3140
2020
Q3 		$165K Buy
+1,614
New +$152K ﹤0.01% 2521
2019
Q4 		– Sell
-1,796
Closed -$163K – 3181
2019
Q3 		$163K Buy
+1,796
New +$181K ﹤0.01% 2914

Other funds holding STRO

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

HSBC Holdings's STRO Position: Q3 2025 in Review

HSBC Holdings sold out of Sutro Biopharma (STRO) in Q3 2025, closing a stake of 2,474 shares — an estimated $18.1K sold.

HSBC Holdings first reported a position in STRO in Q3 2019 and held it in 14 quarters. The position peaked at $313K in Q1 2024. 87 funds tracked by Wall St. Rank hold STRO as of Q3 2025.

  • HSBC Holdings reported no remaining Sutro Biopharma position as of Q3 2025 after selling out during the quarter.
  • HSBC Holdings sold 2,474 Sutro Biopharma shares in Q3 2025, an estimated $18.1K.
  • HSBC Holdings first reported a position in Sutro Biopharma in Q3 2019 and held it in 14 quarters.
  • HSBC Holdings's Sutro Biopharma position peaked at $313K in Q1 2024.
  • 87 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2025.

Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.